FITLIFE BRANDS, INC. Public Float
FITLIFE BRANDS, INC. (FTLF) had Public Float of $50.75 million as of 2025-06-30, per its 10-K/A filed 2026-04-21.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-04-21
- 2025-06-30: Entity Public Float $50.75M.
- 2024-06-30: Entity Public Float $63.79M.
- 2023-06-30: Entity Public Float $32.32M.
- 2022-06-30: Entity Public Float $21.08M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $50.75M 10-K/A · filed 2026-04-21 |
| 2024-06-30 | $63.79M 10-K/A · filed 2025-04-29 |
| 2023-06-30 | $32.32M 10-K/A · filed 2024-04-22 |
| 2022-06-30 | $21.08M 10-K/A · filed 2023-04-27 |
| 2021-06-30 | $19.45M 10-K · filed 2022-10-13 |
| 2021-03-11 | $0.00 10-K · filed 2021-03-26 |
| 2020-06-30 | $5.12M 10-K/A · filed 2022-10-13 |
| 2019-06-30 | $6.17M 10-K · filed 2020-03-30 |
| 2018-06-30 | $3.00M 10-K · filed 2019-03-22 |
| 2017-06-30 | $4.38M 10-K · filed 2018-04-17 |
| 2016-06-30 | $11.70M 10-K · filed 2017-04-17 |
| 2015-06-30 | $9.36M 10-K · filed 2016-04-14 |
| 2014-06-30 | $12.13M 10-K · filed 2015-03-31 |
| 2013-08-09 | $77.75K 10-Q · filed 2013-08-14 |
| 2013-06-30 | $6.79M 10-K · filed 2014-03-28 |
| 2013-05-10 | $77.75K 10-Q · filed 2013-05-14 |
| 2012-11-14 | $74.59K 10-Q · filed 2012-11-14 |
| 2012-08-14 | $744.91K 10-Q · filed 2012-08-14 |
| 2012-06-30 | $3.90M 10-K · filed 2013-04-01 |
| 2011-06-30 | $4.74M 10-K · filed 2012-04-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |